Jason Smith is the Co-Founder of Discovery Therapeutics Caribe and he serves as the company’s Senior Vice President of Program Management and Business Development.Mr. Smith has been instrumental in achieving critical business and regulatory milestones for DTC. He leads DTC’s partnership with the Center for Genetic Engineering and Biotechnology (CIGB), overseeing all aspects of strategic planning, program management, regulatory filings, and business development. His efforts have been crucial in driving the success of DTC’s mission by helping to secure funding, overseeing business negotiations, and managing the company’s day-to-day operations.As SVP, Mr. Smith directs a talented team of scientists, healthcare professionals, clinical and regulatory consultants, and DTC’s collaboration with key opinion leaders (KOLs) in the wound care industry. His leadership was pivotal in the successful submission of DTC’s initial Investigational New Drug (IND) application to conduct a Phase III clinical trial of Heberprot-P® in the United States. Also serving as Director of LNE Group’s Strategic Advisory practice, Jason brings more than 20 years of experience in managing domestic and international funding pursuits and business consulting engagements that achieve client objectives and deliver bottom line results. Jason helps innovative enterprises to develop technological assets into viable products with large commercial potential. Jason also manages client work to secure government funding in the United States and Europe. Jason and his team have secured hundreds of millions of dollars to support client interests, including technology innovation and expansion projects.Jason graduated from Ohio University with a B.B.A. in Marketing, Management, and International Business in 2000 and he earned an M.B.A. in 2003.